dornase alfa

CHEBI:CHEBI_751352

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
205532
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20241231
route
RESPIRATORY (INHALATION)
dosage_form
LIQUID
nui
M0018641
pharm_class_pe
Decreased Respiratory Secretion Viscosity [PE]
pharm_class
Recombinant Proteins [CS]
active_ingredient_strength
14 g/L
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
19931230
package_marketing_start_date
30-DEC-93
labeler_name
Lonza Biologics Tuas Pte Ltd.
manufacturer_name
Genentech, Inc.
generic_name
dornase alfa
product_ndc
50242-100
spl_id
359c139d-b199-4508-9523-97c6f40ef863
active_ingredient_name
DORNASE ALFA
package_ndc
50242-100-40
package_description
5 POUCH in 1 CARTON (50242-100-40) / 6 AMPULE in 1 POUCH (50242-100-39) / 2.5 mL in 1 AMPULE
brand_name
Pulmozyme
brand_name_base
Pulmozyme
application_number
BLA103532
unii
953A26OA1Y
spl_set_id
d8c78a7e-ff99-48f3-8952-643ec2ea0f86
pharm_class_epc
Recombinant Human Deoxyribonuclease 1 [EPC]
pharm_class_cs
Recombinant Proteins [CS]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class